Toxic Metabolite Clearance Platform
Age-related diseases (e.g., diabetic complications, neurodegeneration)
PreclinicalActive
Key Facts
Indication
Age-related diseases (e.g., diabetic complications, neurodegeneration)
Phase
Preclinical
Status
Active
Company
About Revel Pharmaceuticals
Revel Pharmaceuticals is a private, preclinical-stage biotech targeting the fundamental biology of aging and age-related diseases. The company's platform aims to develop therapies that clear toxic accumulations and repair damage, positioning it in the emerging longevity and chronic disease space. With a lean team and a scientific advisory board featuring experts in glycation and aging biology, Revel is building its foundational technology. The company is currently pre-revenue and focused on early-stage research and development.
View full company profile